share_log

The Total Return for Hubei Xingfa Chemicals Group (SHSE:600141) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years

The Total Return for Hubei Xingfa Chemicals Group (SHSE:600141) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years

在过去五年中,湖北兴发化工集团(SHSE: 600141)投资者的总回报增长速度快于收益增长
Simply Wall St ·  01/11 19:38

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the market average. And the truth is, you can make significant gains if you buy good quality businesses at the right price. To wit, the Hubei Xingfa Chemicals Group share price has climbed 83% in five years, easily topping the market return of 25% (ignoring dividends).

一般而言,积极选股的目的是寻找回报优于市场平均水平的公司。事实是,如果你以合适的价格购买高质量的企业,你可以获得可观的收益。换句话说,湖北兴发化工集团的股价在五年内上涨了83%,轻松超过了25%的市场回报率(不计股息)。

Although Hubei Xingfa Chemicals Group has shed CN¥711m from its market cap this week, let's take a look at its longer term fundamental trends and see if they've driven returns.

尽管湖北兴发化工集团本周的市值下跌了7.11亿元人民币,但让我们来看看其长期基本面趋势,看看它们是否推动了回报。

See our latest analysis for Hubei Xingfa Chemicals Group

查看我们对湖北兴发化工集团的最新分析

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

不可否认的是,市场有时是有效的,但价格并不总是能反映基本的业务表现。评估公司情绪变化的一种有缺陷但合理的方法是将每股收益(EPS)与股价进行比较。

During five years of share price growth, Hubei Xingfa Chemicals Group achieved compound earnings per share (EPS) growth of 37% per year. This EPS growth is higher than the 13% average annual increase in the share price. So one could conclude that the broader market has become more cautious towards the stock. The reasonably low P/E ratio of 7.17 also suggests market apprehension.

在五年的股价增长中,湖北兴发化工集团实现了每年37%的复合每股收益(EPS)增长。每股收益的增长高于股价年均增长13%。因此,人们可以得出结论,整个市场对该股变得更加谨慎。相当低的市盈率为7.17,也表明了市场的担忧。

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

下图描绘了 EPS 随着时间的推移而发生的变化(点击图片显示确切的数值)。

earnings-per-share-growth
SHSE:600141 Earnings Per Share Growth January 12th 2024
SHSE: 600141 每股收益增长 2024 年 1 月 12 日

We know that Hubei Xingfa Chemicals Group has improved its bottom line over the last three years, but what does the future have in store? You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

我们知道湖北兴发化工集团在过去三年中提高了利润,但是未来会发生什么?您可以在这张免费的交互式图片中看到其资产负债表如何随着时间的推移而增强(或减弱)。

What About Dividends?

那股息呢?

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. We note that for Hubei Xingfa Chemicals Group the TSR over the last 5 years was 101%, which is better than the share price return mentioned above. This is largely a result of its dividend payments!

在考虑投资回报时,重要的是要考虑两者之间的区别 股东总回报率 (TSR) 和 股价回报。股东总回报率是一种回报计算方法,它考虑了现金分红的价值(假设收到的任何股息都经过再投资)以及任何贴现资本筹集和分拆的计算价值。可以说,股东总回报率更全面地描述了股票产生的回报。我们注意到,湖北兴发化工集团过去5年的股东总回报率为101%,好于上述股价回报率。这在很大程度上是其股息支付的结果!

A Different Perspective

不同的视角

We regret to report that Hubei Xingfa Chemicals Group shareholders are down 36% for the year (even including dividends). Unfortunately, that's worse than the broader market decline of 13%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. On the bright side, long term shareholders have made money, with a gain of 15% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It's always interesting to track share price performance over the longer term. But to understand Hubei Xingfa Chemicals Group better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 4 warning signs with Hubei Xingfa Chemicals Group (at least 1 which doesn't sit too well with us) , and understanding them should be part of your investment process.

我们遗憾地报告,湖北兴发化工集团的股东今年下跌了36%(甚至包括股息)。不幸的是,这比整个市场13%的跌幅还要严重。话虽如此,在下跌的市场中,一些股票不可避免地会被超卖。关键是要密切关注基本发展。好的一面是,长期股东赚了钱,在过去的五年中,每年增长15%。最近的抛售可能是一个机会,因此可能值得查看基本面数据以寻找长期增长趋势的迹象。长期跟踪股价表现总是很有意思的。但是,要更好地了解湖北兴发化工集团,我们需要考虑许多其他因素。例如,投资风险的幽灵无处不在。我们已经向湖北兴发化工集团确定了4个警告信号(至少有1个不太适合我们),了解这些信号应该是您投资过程的一部分。

We will like Hubei Xingfa Chemicals Group better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我们看到一些重大的内幕收购,我们会更喜欢湖北兴发化工集团。在我们等待的同时,请查看这份免费清单,列出了最近有大量内幕收购的成长型公司。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

请注意,本文引用的市场回报反映了目前在中国交易所交易的股票的市场加权平均回报率。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St 的这篇文章本质上是笼统的。我们仅使用公正的方法提供基于历史数据和分析师预测的评论,我们的文章并非旨在提供财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不会考虑最新的价格敏感型公司公告或定性材料。华尔街只是没有持有上述任何股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发